Home > Insider Trading > Filing (0001209191-23-023658)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1651944	Dermtech Inc.	DMTK	Services-Medical Laboratories (8071)	842870849

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1787176	John Dobak	C/O Dermtech, Inc. 12340 El Camino Real San Diego CA 92130	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-03-09	56,407	$0.00	700,252	No	4	A	Direct
Common Stock	Disposition	2023-03-13	1,559	$3.26	698,693	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	S	Direct

Footnotes

Footnote No. 1 in the Form 4 originally filed on March 13, 2023 contained an error regarding the vesting schedule of the restricted stock units awarded to the reporting person. Footnote No. 1 is hereby corrected as follows: The securities awarded are in the form of restricted stock units issued pursuant to the issuer's 2020 Equity Incentive Plan and the terms of a Transition Agreement, dated March 1, 2023, between the reporting person and the issuer. Each restricted stock unit represents a contingent right to receive one share of issuer common stock. Subject to the reporting person's continued service, (i) one-third (1/3) of the restricted stock units shall vest on June 5, 2023 and (ii) the remaining two-thirds (2/3) shall vest in two (2) equal installments of one-third (1/3) on the fifth day of each third month following June 5, 2023 until the final vesting date onDecember 5, 2023.
The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on June 25, 2020.